Rocket, Labs

Rocket Lab's 96-Launch Streak Meets a $1.94 Billion Bet on Iridium

Published on 09/24/2026 at 07:30 | Editorial boerse-global.de

Electron's 17th 2025 launch lifts a Synspective radar satellite, but Rocket Lab's valuation now hinges on Neutron and the Iridium deal.

Rocket Lab's Electron Hits 96 Missions as Neutron and Iridium Define the Bet
Rocket Lab's 96-Launch Streak Meets a $1.94 Billion Bet on Iridium Illustration mit AI erstellt.

Rocket Lab's Electron rocket keeps delivering the kind of reliability that is hard to come by in the launch business. On Saturday, the company placed a StriX satellite for Japanese customer Synspective into a polar orbit at an altitude of 572 kilometers, marking the 96th Electron mission overall and the 17th flight of the year. The payload — the twelfth satellite in Synspective's synthetic-aperture radar constellation — was deployed without incident under a mission dubbed "Owl By The Dozen."

That relationship has legs well beyond a single flight. Fifteen further dedicated Electron missions for Synspective are already on the manifest through the end of the decade, giving the launch provider a predictable, multi-year revenue stream. The previous flight, "Happily Ever Faster," lifted off on September 11 and carried an Earth-observation satellite for a confidential customer into a circular orbit at 500 kilometers — Rocket Lab's 16th launch of 2025.

Two Megaprojects Define the Investment Case

Smooth Electron cadence, however, no longer tells the whole story. At a market capitalization of EUR 35.94 billion, Rocket Lab's valuation rests on far heavier machinery: the development of the medium-lift Neutron rocket and the multi-billion-dollar absorption of Iridium Communications.

Neutron preparations are gathering pace. The company recently wrapped up tests of the reusable payload fairing and installed a ten-meter test stand for the second stage in the US state of Virginia. Cantor Fitzgerald reaffirmed its "Overweight" rating on Monday with a $122 price target, calling Neutron the only viable alternative and the most direct commercial challenger to SpaceX's Falcon 9.

Should investors sell immediately? Or is it worth buying Rocket Lab?

That confidence carries real downside risk. Heavy-lift rockets are unforgiving in development. Engine tests directly on the pad and the upcoming first-stage hot-fire trials will reveal how credible the timeline truly is. Delays of quarters, or even years, are closer to the norm than the exception at this stage of a launch vehicle's life.

Financing Is Done — Execution Is Not

The financial groundwork for the expansion is largely complete. Rocket Lab closed a $1.944 billion capital raise in mid-September by issuing roughly 29.3 million new shares. Together with an existing $1.775 billion credit facility from Iridium, the planned acquisition of the satellite network operator is fully funded. The deal is expected to close in mid-2027, subject to regulatory approvals; the FCC accepted the relevant license-transfer applications about a week ago.

Dilution is the price existing shareholders pay for the pivot toward a vertically integrated space company. Analyst Brian Gesuale of Raymond James flagged the execution risks plainly in his September 11 initiation at "Outperform" with an $80 target, pointing to the Neutron program alongside the integration of Mynaric and the Iridium purchase. Until Rocket Lab can post positive operating income and free cash flow — a milestone management has sketched for 2027 or 2028 — the company is running lean.

Insider Sales and a Halved Share Price

That backdrop gives context to recent share sales by CFO Adam C. Spice and COO Frank Klein, who offloaded million-dollar stakes through pre-arranged trading plans. The moves do not signal a loss of confidence, but they are a reminder that management knows exactly how long and steep the road to profitability remains.

The stock closed yesterday at EUR 61.70, down 1.9%, and has lost more than half its value from a 52-week high of EUR 133.80. The pullback reflects mounting skepticism about whether the company can juggle costly development and operational expansion without further bruises. On the component side, production of the Inverted Metamorphic Apex solar cell began roughly two weeks ago, broadening the portfolio.

The technological promise is real, but the near-term risk-reward skews cautious. Neutron's first hot fires and the Iridium closing are binary events — capable of lifting the shares sharply or hitting them hard on any setback. For now, watching the big rocket's first ignition attempts from the sidelines looks like the more sensible position.

Ad

Rocket Lab Stock: New Analysis - 24 September

Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab analysis...

Disclaimer...

en | US7731211089 | ROCKET | boerse | 70174222 |